|
|
Dear Readers,
Welcome to the November / December 2020 edition of the Funding Strategies newsletter! |
November has seen a number of launches and updates. You can find out more here: |
This edition of our newsletter includes: |
As this is our final newsletter for 2020, we would like to take this opportunity to thank all our valued clients and associates for doing business with us and to wish you all a very Merry Christmas and a Happy New Year! |
|
About Funding Strategies
Funding Strategies is a capital markets firm providing venture equity capital and finance services to small business and companies seeking capital for growth and expansion in the unlisted and pre-IPO capital markets.
We specialise in creating and implementing successful funding and capital raising strategies for issuers, and provide investment opportunities in the high growth alternative asset space for investors.
We serve predominately private and public companies, and sophisticated investors, with a broad range of services. - Funding Strategies and Investor Ready Services
- Equity and Debt Capital Raisings
- Small Scale Offerings and Venture Capital
- Grant Funding
- Migration linked investment
- Mergers,Acquisitions and Divestments
- Strategic Trade Sales
- Technology Commercialization
- Providing Opportunities for Investors
- Director and business advisory services
- Investment management
- Fund management services
|
As always, we invite you to from our website (registration / log-in required, membership is free).
|
|
|
|
For more information please contact us. We look forward to hearing from you! |
|
|
|
|
|
International Supply Chain
Brett Perkins from our team (pictured left) has put the following article together about the international supply chain.
"We are currently experiencing unprecedented change in Australia’s trading relationships within the South East Asia region and international uncertainty as a result of the US elections and enduring impact of COVID-19. |
|
|
|
Traditional supply chains and the status quo are coming under increasing pressure as
existing value chains and loyalties are tested through a combination of
international trade relationships, diplomatic and political pressure.
The
emergence of the Supply Chain Resilience Initiative (SCRI), the result of a
trilateral engagement between Japan, India and Australia is one such
development that looks to respond to these uncertainties.
Our
multi-national team that covers the Asian, Indo-Pacific, American and European
geographies is able to immediately leverage our local knowledge of in-country
business customs and trusted relationships to offer a level of reach that is
difficult to establish quickly or easily.
Let
our extensive international experience and global
network strengthen your ability to solve existing problems or identify new
opportunities across: - Product Sourcing (with a focus on SE Asia) and Supplier
Management
- Domestic and International:
- Supply Chain and Logistics
- Product Distribution
- Governance, Risk and Compliance
For
a confidential, obligation free session or just more information, please
contact us via email or phone on +61 7 3160 2840. |
|
|
|
|
|
Funding Strategies Signs Co-Operation Agreement With Cluster Biotechnology
Funding Strategies is pleased to announce that it has signed a Co-operation Agreement with Cluster Biotechnology to support each other and their clients around the services both organisations provide.
Cluster Biotechnology, based on the Gold Coast, provides world class laboratory facilities to support science innovation in biotechnology and chemistry. Through their scientific work they have been solving complex problems for their clients in the agtech, foodtech and biotech spaces and developed novel products and formulations.
Funding Strategies' Managing Director, Dr Mark Rainbird, states: "From a Funding Strategies point-of-view we have a partner that we can work with that helps solves our clients problems and helps them to develop new products and validates the science and testing needed to progress. |
|
|
|
In turn, Cluster assists Funding Strategies in supporting our clients around strategy, formulation, product development, go-to-market and funding (including grant funding)."
Dr. Gustavo Cerqueira from Cluster Biotechnology commented that the complementary strengths between the two organisations was significant and we look forward to assisting Funding Strategies and its clients with world class science and laboratory facilities”. |
|
|
|
|
|
Introducing Pharmachal Health Group
Pharmachal researches, formulates, develops and manufactures pharmaceutical, medical, healthcare and veterinary products |
|
|
|
Pharmachal Health Group is a Melbourne-based, globally-focused company that researches, develops and distributes a range of pharmaceutical products. The Company prides itself of producing high-quality, scientifically-validated products with solid value propositions that are produced by GMP Code of Practice-approved manufacturers.
The Company’s cornerstone asset is the revolutionary, internationally patented, mini-emulsion Nano Drug DeliverySystem (NDDS) that can deliver a range of APIs (active ingredients i.e. drugs) as a spray, patch, cream or sublingual oral product. The nanoscopic particle size associated with the technology allows drugs to be delivered with unprecedented efficacy, presenting opportunities to replace injections with sprays, patches or creams.
Successful trials have been concluded with NOPAYNETM, a lidocaine-based product using the Novel Drug Delivery System (NDDS) technology. NOPAYNE will soon be used to reduce pain for multiple painful conditions, including shingles, eczema, burns, bites and open cuts and wounds. Each of these conditions represents a substantial market and NOPAYNE will be able to competevery effectively in all of these markets with an appropriate format, marketingand pricing strategy. |
|
|
|
|
|
Enviro Sand update
Enviro Sand scores two major 2020 Brisbane Lord Mayor's business awards & Round 1 of its capital raise is fully subscribed, raising $1m
|
|
|
|
Queensland-based Enviro Sand has beaten off stiff competition to be named the winner of two (2) of the most prestigious 2020 Brisbane Lord Mayor's Business Awards, earning themselves the Urban Utilities Award for Product Innovation as well as the Yurika Award for Environmental Sustainability in Business.
In other news, the Company is also pleased to announce that Round 1 of its capital raise is fully subscribed, raising $1m to enable the current relocation to, and commissioning of, a new plant at Wacol, with the remaining funds being allocated to increased production capacity, an extensive trade marketing and advertising campaign, as well as working capital.
|
|
|
|
|
|
Wildfire Energy update
Wildfire Energy joins
Brinc’s Australia CleanTech Accelerator
|
|
|
|
Congratulationsto Wildfire Energy (Project Ignis) who joins the Brinc Australia CleanTech accelerator program, closing out Round 1 of Wildfire Energy's capital raise!
Brinc is a venture capital and accelerator firm. The program invests $150,000 into each startup accepted.
|
|
|
|
Brinc states: "Brinc is excited to welcome Wildfire Energy into the Brinc Australia CleanTech accelerator program. Wildfire Energy is the first cleantech startup to join the Brinc family since we announced our plan to invest in over 1,000 climate-conscious startups in the next 5 years."
Greg Perkins, Co-founder & Managing Director of Wildfire Energy said: "The Brinc CleanTech accelerator has proven to be an advantage with the support from dedicated global experts and advisors, which has strengthened our business plan and deployment strategy. The funding from Brinc and Artesian will allow Wildfire Energy to upgrade our pilot plant and finalise commercial designs, taking our company to a whole new level. The MIHG technology is the global leader in the distributed energy from waste industry, enabling the production of cleaner energy and the full benefits of a circular economy to be realised.” |
|
|
|
|
|
CareVision update
CareVision features on MergerMarket |
|
|
|
"CareVision, a Sydney-based health tech for the aged and disability care sectors, is actively seeking offshore market entry options ahead of an IPO in two to three |
|
|
|
years, or sooner,depending on how quickly it expands, said co-founder and Director Irene Ryan. [...]
The company uses AI and machine-learning driven software to provide an end-to-endsolution to connect all stakeholders in the retirement living, aged care anddisability care sectors including care givers, clients and families, Ryan said.Functionality includes care scheduling, budgeting, automated time-sheeting,clinical care documentation, and client and family portals and apps. [...]
In 2019,aged care services subsidised by the Australian government were provided to1.3m people and it is estimated that by 2023, 1.5m people will be accessingsubsidised services, Ryan said. There are 4.3m people living with a disability,with the government providing more than AUD 22bn under its National DisabilityInsurance Scheme (NDIS), she added."
|
|
|
|
|
|
BRICKLET update
"Buy Now Pay Later For Property Is Here!
|
|
|
|
Own your own property future with Buy Now Pay Later bricklets:
- Buy a bricklet.
- Pay for it over 18 months.
- No interest.
- No charges.
Simple. It’s now a reality. Buy Now Pay Later bricklets are now available in Brisbane, Sydney and Melbourne.
BRICKLET has pioneered independent part ownership of property. Succeeding to create genuine property ownership through fragmentation. It’s been operating since 2019 and has already enabled thousands of Australians increase their property investment portfolio. Some have diversified their property holdings, others have climbed the first rung of the property ladder. For as little as $25,000. Now offering Buy Now Pay Later." |
|
|
|
|
|
BlueMount Capital updates:
Introducing Project Luxuria
|
|
|
|
Project Luxuria specialises in identifying and developing medium to high density extraluxury residential properties. In addition, the Company has extensive experience in advising and managing the development process for commercial properties, hotels and retail for its clients.
Project Luxuria’s team consists of people with adiverse and extensive background in the property industry with a track record of delivering successful projects in Australia. |
|
|
|
Project Luxuria recently completed projects in Toowong (Brisbane, pictured above left), and Broadbeach (Gold Coast, pictured above right). The Company has also completed many design and management consultancy roles for corporate clients. |
|
|
|
|
|
BlueMount Capital updates:
Introducing Project Terebro
|
|
|
|
Project Terebro build custom equipment specific to its customer’s needs and specifications. The Company builds new rigs based on its proven designs, customises existing rigs, including upgrades to client specific requirements, electric or hydraulic top drives, rod handling solutions, mud circulation systems, platforms, jack-ups and a variety of pad configurations, to enhance performance as well as back up component supply. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BlueMount Capital updates:
Project Portus update
|
|
|
|
BlueMount Capital client Venice Energy (Project Portus) recently featured in the Australian Financial Review: "SA gas importer plans listing to support $200m terminal" |
|
|
|
"A public listing of Venice Energy next year is part of the plan to help fund the project, which could start importing gas into South Australia by October 2022, depending on approvals, Mr Winter-Dewhirst said.
"We've been working on this structure for quite some time, we are a significant way down the road on this," he said of the listing plan, which is tentatively slated for mid-2021." |
|
|
|
|
|
BlueMount Capital updates:
XING update
|
|
|
|
BlueMount Capital client XING recently featured on Tomorrow's Tech:
"Rapid Diagnostics in the Covid-19 Era with Paul Mainwaring | Tomorrow's Tech |
|
|
|
Xing Technologies’ fast diagnostics solutions for COVID-19 has received support from the Australian Government CSIRO, United States National Institutes of Health (NIH), and the Queensland Government, as a global contender to help people safely return to their everyday lives. In this episode of Tomorrow’s Tech, Paul Mainwaring shares deep insights into the new advancements of their COVID-19 test which will revolutionise the way the medical world has been diagnosing coronavirus." |
|
|
|
"Tomorrow’s Tech is an online TV Channel, helping entrepreneurs and business leaders develop and commercialise their technology innovations. We engage with successful entrepreneurs, investors, board members, and industry leaders to bring you battle-tested advice for innovation success."
|
|
|
|
|
|
BlueMount Capital updates:
Project Linteum update
|
|
|
|
BlueMount Capital client Project Linteum has provided the following update:
Project Linteum given green light for clinical trial
"We are pleased to announce that ethics approval has been granted by [a local hospital] for clinical trial of our prototype device.
|
|
|
|
|
|
|
|
|
|
The trial will collect proof-of-concept data from healthy volunteers and patients including relevant feasibility and usability data to develop our pressure injury risk management technology. Further refinement of our technology to meet clinician and patient needs will enable us to offer a targeted, patient-specific solution that does not exist in the market today. Recruitment for the trial is expected to begin in early 2021." |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
You are receiving this email because you are a valued contact and have provided us with your details in the past. If you ever wish to change your personal details simply update your profile, or to unsubscribe, click the unsubscribe link located at the bottom of any of our emails.
This email is not an offer to invest in securities and is made in accordance with section 708 of the Corporations Act.
If you have received this email in error, please email with the Subject line of "Unsubscribe" or alternatively
click the unsubscribe link located at the bottom of any of our emails. |
|
|
|
